| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-88 |
Sentence |
denotes |
Resistance to human serum of gonococci in urethral exudates is reduced by neuraminidase. |
| T1 |
0-88 |
Sentence |
denotes |
Resistance to human serum of gonococci in urethral exudates is reduced by neuraminidase. |
| T2 |
89-231 |
Sentence |
denotes |
Gonococci examined directly from urethral exudates are resistant to killing by human serum, but most strains become susceptible on subculture. |
| T2 |
89-231 |
Sentence |
denotes |
Gonococci examined directly from urethral exudates are resistant to killing by human serum, but most strains become susceptible on subculture. |
| T3 |
232-573 |
Sentence |
denotes |
Previous work with gonococci grown in vitro indicates that resistance in vivo is due to sialylation of gonococcal lipopolysaccharide (LPS) by a host factor, cytidine 5'-monophospho-N-acetylneuraminic acid (CMP-NANA) or a related compound present in urogenital secretions and blood cells including phagocytes, which exude during inflammation. |
| T3 |
232-573 |
Sentence |
denotes |
Previous work with gonococci grown in vitro indicates that resistance in vivo is due to sialylation of gonococcal lipopolysaccharide (LPS) by a host factor, cytidine 5'-monophospho-N-acetylneuraminic acid (CMP-NANA) or a related compound present in urogenital secretions and blood cells including phagocytes, which exude during inflammation. |
| T4 |
574-672 |
Sentence |
denotes |
This sialylation inhibits the reaction between bactericidal IgM in serum and its target LPS sites. |
| T4 |
574-672 |
Sentence |
denotes |
This sialylation inhibits the reaction between bactericidal IgM in serum and its target LPS sites. |
| T5 |
673-738 |
Sentence |
denotes |
Here, we confirm the indication by using gonococci grown in vivo. |
| T5 |
673-738 |
Sentence |
denotes |
Here, we confirm the indication by using gonococci grown in vivo. |
| T6 |
739-922 |
Sentence |
denotes |
Crucial to the above conclusions was the marked reduction of CMP-NANA-conferred serum resistance when gonococci were treated with neuraminidase to remove sialyl groups from their LPS. |
| T6 |
739-922 |
Sentence |
denotes |
Crucial to the above conclusions was the marked reduction of CMP-NANA-conferred serum resistance when gonococci were treated with neuraminidase to remove sialyl groups from their LPS. |
| T7 |
923-1172 |
Sentence |
denotes |
We now show that the serum resistance of gonococci in urethral exudates was reduced by treatment with neuraminidase from more than 95% (calculated in relation to controls incubated with heated serum) to 2-11% according to sample and incubation time. |
| T7 |
923-1172 |
Sentence |
denotes |
We now show that the serum resistance of gonococci in urethral exudates was reduced by treatment with neuraminidase from more than 95% (calculated in relation to controls incubated with heated serum) to 2-11% according to sample and incubation time. |
| T8 |
1173-1307 |
Sentence |
denotes |
Subculture of the gonococci also reduced resistance to 9-11% but resistance was restored to more than 95% by incubation with CMP-NANA. |
| T8 |
1173-1307 |
Sentence |
denotes |
Subculture of the gonococci also reduced resistance to 9-11% but resistance was restored to more than 95% by incubation with CMP-NANA. |
| T9 |
1308-1502 |
Sentence |
denotes |
This work is the culmination of an investigation that underlines the need to identify specific host factors and the virulence determinants they induce in vivo in future studies of pathogenicity. |
| T9 |
1308-1502 |
Sentence |
denotes |
This work is the culmination of an investigation that underlines the need to identify specific host factors and the virulence determinants they induce in vivo in future studies of pathogenicity. |